The Caris Biorepository Research Protocol
The Caris Biorepository Research Protocol
The Biorepository for Caris Life Sciences is designed for the purpose of making quality biospecimens and associated clinical data available for research studies related to advancing precision medicine and improving care for patients.
The Caris Biorepository is a repository of prospectively collected biological specimens and associated clinical and demographic data gathered from multiple sources to be stored, used and shared for research. Caris Life Sciences will maintain the data and specimens and will control access to and use of the information and specimens by multiple individuals for multiple purposes which may evolve over time.
The Caris Biorepository is an effort toward defining the future of medicine incorporating the discoveries of the genomic era by providing physicians, researchers and scientists access to quality human specimens and data aimed at improving human health and fighting disease. This will be accomplished through acquiring and sharing valuable biospecimen information and clinical outcomes in a collaborative, secure environment. The Caris Biorepository will bridge the gap and correlate human specimens with clinical and specimen data valuable to multiple and varying entities interested in advancing science with precision medicine by targeting disease treatments.
The objective of this project is to develop and implement a state-of-the-science Biorepository that ensures molecular integrity and clinical relevance of human biospecimens used in research and clinical medicine. The Caris Biorepository will also provide vital biospecimens and data to internal researchers and external research collaborators such as government, academia and industry collaborators for the use of drug development discoveries, clinically relevant research trials, publications and posters, and the implementation of future healthcare policies. This project may also impact characterization of trends in practice patterns and their relation to patient outcomes as well as the economic implications of differing evaluation, treatment and management paradigms.
Inclusion Criteria:
Exclusion Criteria:
carisresearch@carisls.com
Mobile, Alabama, United States
tnfulford@health.southalabama.edu251-445-3276
Charleston, South Carolina, United States
ECrampton@esmil.com480-425-4055
dlking@sbrmc.org870-207-8157
Jesse.Byrd@Carti.com501-561-2205
Cynthia.Whitcomb@objective.health501-214-0372
juliana.turner@leehealth.org239-343-9660
Natalie.Espenship@cancercareofnorthflorida.com386-755-1655
Corina.Mattix@AdventHealth.com407-303-1327
bborresen@tgh.org727-612-4026
HAMMONB7@ccf.org954-487-2257
229-312-0354
cegbueo@emory.edu404-778-8027
ALWARD@augusta.edu706-721-1623
research@ccmgeorgia.com478-272-8266 ext. 321
abaftirovska@hopenheal.care630 560 0121 ext. 107
crystal.dubois2@christushealth.org318-528-5137
pbhandari@tulane.edu504-988-6053
thea.spencer@christushealth.org318-681-6007
rkim1@mdmercy.com410-951-7908
Pnickole@lifebridgehealth.org410-601-6120
Gloria.Simmons@forrestgeneral.com601-288-2494
tdavis@jacksononcology.com601-974-5547
trobinson13@umc.edu601-815-2123
Lori.Walsh@objective.health862-294-0418
Miquela.Gutierrez@stvin.org505-913-8822
McKenna.Boula@rochesterregional.org315-261-6319
ssmaragdas@nycancer.com631-675-5103
ATATUM@altru.org701-780-1563
tpicino@neourology.com330-729-9214 ext. 240
cvazquez@thectnx.com216-372-0505
mklinskicox@summithealth.com541-706-5339
Aindrea.Maddray@rsfh.com843-724-2204
kmertz-Rivera@gibbscc.org864-560-6104
msmith@WESTCLINIC.com901-683-0055 ext. 62739
Lauren.Kuehler@objective.health806-641-0256
kimberly.everett@christushealth.org903-614-6885
kristi.sutphin@CAMC.org304-388-9945
ahuppert@mhemail.org608-756-6695